Permeability of the reconstructed human epidermis model Episkin® in comparison to various human skin preparations

被引:81
作者
Netzlaff, Frank
Kaca, Monika
Bock, Udo
Haltner-Ukomadu, Eleonore
Meiers, Peter
Lehr, Claus-Michael
Schaefer, Ulrich F.
机构
[1] Univ Saarland, D-6600 Saarbrucken, Germany
[2] Across Barriers GmbH, Saarbrucken, Germany
关键词
Episkin (R); testosterone; caffeine; stratum corneum; heat-separated human epidermis; split thickness skin; full thickness skin; skin lipids;
D O I
10.1016/j.ejpb.2006.08.012
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The objective of this work was to compare the barrier function of the small diameter reconstructed human epidermis model Episkin((R)) (d = 12 mm) to human skin in vitro. For that purpose a modification for the Franz diffusion cell (d = 15 mm) had to be developed so as to allow direct comparison with the following human skin preparations: Full thickness skin (FTS), split thickness skin (STS), heat-separated epidermis (HSE), and trypsin isolated stratum corneum (TISC). Among the tested preparations, HSE appeared to be the most preferable due to its clear morphological structure and case of preparation. The lipid profile of HSE and Episkin((R)) was analyzed and showed significant differences in terms of cholesterol, ceramides and triglycerides contents, whereas cholesterol esters and fatty acids were not different. Permeation data with HSE and Episkin((R)) were then gathered using caffeine and testosterone. Both test compounds permeated much faster through Episkin((R)) than through HSE. Moreover, opposed to Episkin((R)), HSE differentiated between the two test compounds. In spite of the remarkable progress in developing RHEs in the past years at this time Episkin((R)) can obviously not yet fully replace human skin for in vitro permeability experiments. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 33 条
[1]
Boelsma E, 2000, ACTA DERM-VENEREOL, V80, P82
[2]
BOUWSTRA JA, 1995, J LIPID RES, V36, P685
[3]
BOUWSTRA JA, 1997, MECH TRANSDERMAL DRU, P41
[4]
Inter- and intralaboratory variation of in vitro diffusion cell measurements:: An international multicenter study using quasi-standardized methods and materials [J].
Chilcott, RP ;
Barai, N ;
Beezer, AE ;
Brain, SI ;
Brown, MB ;
Bunge, AL ;
Burgess, SE ;
Cross, S ;
Dalton, CH ;
Dias, M ;
Farinha, A ;
Finnin, BC ;
Gallagher, SJ ;
Green, DM ;
Gunt, H ;
Gwyther, RL ;
Heard, CM ;
Jarvis, CA ;
Kamiyama, F ;
Kasting, GB ;
Ley, EE ;
Lim, ST ;
Mcnaughton, GS ;
Morris, A ;
Nazemi, MH ;
Pellett, MA ;
Du Plessis, J ;
Quan, YS ;
Raghavan, SL ;
Roberts, M ;
Romonchuk, W ;
Roper, CS ;
Schenk, D ;
Simonsen, L ;
Simpson, A ;
Traversa, BD ;
Trottet, L ;
Watkinson, A ;
Wilkinson, SC ;
Williams, FM ;
Yamamoto, A ;
Hadgraft, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (03) :632-638
[5]
DREHER F, 2002, SKIN PHARM APPL S S1, V15
[6]
*EC, 2004, GUID DOC DERM ABS EU
[7]
ELIAS PM, 1991, ADV LIPID RES, V24, P1
[8]
PERCUTANEOUS TRANSPORT IN RELATION TO STRATUM-CORNEUM STRUCTURE AND LIPID-COMPOSITION [J].
ELIAS, PM ;
COOPER, ER ;
KORC, A ;
BROWN, BE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 76 (04) :297-301
[9]
*FDA, GUID IND SUPAC SS IN
[10]
Fick A., 1855, Ann. der Phys. und Chemie, V170, P59, DOI [DOI 10.1002/ANDP.18551700105, 10.1002/andp.18551700105]